**** ********** *****, *. **********, SC ***** 843-***-****

acfh9h@r.postjobfree.com

April M. Bell

Objective To obtain a position that will utilize my skills and knowledge.

Experience

**** ******t National Allergy and Asthma Centers North Charleston, SC

Clinical Research Coordinator

Obtained patient work up

Coordinated 6+ investigational drug studies for well known drug companies

Performed EKG and venipuncture

Obtained vitals and reviewed patient medication

Data Entry for all drug studies

Regulatory documents for all drug studies

Budget and Contract for all drug studies

Creation of Source Document’s for all drug studies

Correspondence and on call for all drug studies

Pharmacy & Labs & Drug for subjects on all drug studies

Accountability for study drug

Assisting in and preparing for monitoring visits from sponsors

Assisting in and preparing for Audits from sponsors

Recruitment for subjects for all drug studies

Studies I have conducted upon request

2007 2011 The Neurology and Pain Clinic Orangeburg, SC

Medical Asst., Billing Asst., Office Management Asst., Drug study Coordinator

Assist in management duties upon request per Office Manager

Obtained patient work up

Coordinated 6+ investigational drug studies for well known drug companies

Performed EKG and venipuncture when needed

Obtained vitals and reviewed patient medication

Intramuscular injections

Billing and coding per ICD 9

Data Entry for all drug studies

Regulatory documents for all drug studies

Budget and Contract for all drug studies

Creation of Source Document’s for all drug studies

Correspondence and on call for all drug studies

Pharmacy & Labs & Drug for subjects on all drug studies

Accountability for study drug

Assisting in and preparing for monitoring visits from sponsors

Assisting in and preparing for Audits from sponsors

Recruitment for subjects for all drug studies

Studies I have conducted upon request

Dec/2007 Dr.’s Care N. Charleston, SC

Medical Office Assistant,

Scheduled appointments

Checked patients in & out

Filing

Bookkeeping, and accounting

Basic receptionist duties including scheduling, answering phone, Faxing, etc.

Feb/2007 Parkwood Orthopaedic West Ashley, SC

Medical Office Assistant,

checked in patients, scheduled appointments, answered phone, filed and

pulled charts, assisted doctor with patients, daily deposits and accounting

Aug/2004 Bruns Monumental Co. Columbia, SC

Asst. Manager,

Daily Management decisions

Basic receptionist duties including scheduling, answering phone,

Faxing, etc.

Filing

Bookkeeping and Accounting

Payroll and Daily Deposit’s

Producing Sales for product

Feb/2000 Superior Honda Orangeburg, SC

Receptionist

Basic receptionist duties including scheduling, answering phone,

Faxing, etc.

Filing

Bookkeeping and Accounting

Payroll and Daily Deposit’s

Customer Service for Parts & Service Department

Education Special Skills: Cordova, SC

Windows 95, Windows 98, Windows 99, Windows XP,

Microsoft Word & Excel (93 2007 version’s)

Companion Software

Misys Software

ECW Software

High School Diploma Cordova, SC

Diploma in Education, May 1999

Cope Vocational School Cope, SC

1 yr. Completion in Health Occupations

Certificates: Orangeburg & Charleston, SC

(NIH) Protecting Human Research Participants

Completion: 8/13/2009

Certificate # 266571

Completion: 1/20/2013

Certificate # 1084365

eResearch Technology, Inc.

ECG Certificate (PAT100)

Completion: 9/15/2009

eResearch Technology, Inc.

ECG Certificate Mortara ELI 150 RX (EQP108)

Completion: 9/15/2009

Quintiles QECG

ELI 250 Electrocardiograph Certificate

Completion: 4/07/2010

Credentialing Insurance

Completion: 5/23/2011

Certificate # 123367

Compliance Fraud, Waste and Abuse Training Insurance

Completion: 5/13/2011

Certificate # 921560

Good Clinical Practice updated

Completion: 12/19/2011

Adult, Child, Infant CPR/AED Certificate

Completion: 12/30/2012

Expires: 12/30/2014

ID# A454605

Certificates of Attendance: Orangeburg, SC

Continuing Education Credits

Consortium for Advancements in Health & Human Services

1 HR Completion: 12/15/2010

Code: CM2050

Certificate # A203

Expires: 10/31/2012

1 HR Completion: 1/06/2011

Code: CM2050

Certificate # A205

Expires: 10/31/2012

1 HR Completion: 1/20/2011

Code: CM2050

Certificate # A206

Expires: 10/31/2012

1 HR Completion: 2/03/2011

Code: CM2050

Certificate # A201

Expires: 10/31/2012

1 HR Completion: 3/24/2011

Code: CM2050

Certificate # A211

Expires: 10/31/2012

Skills Working knowledge of computers, copier, fax machine, and other basic office equipment.

Excellent organizational communication, interpersonal and time management skills. Strong

work ethic, highly motivated self starter dedicated to quality service.

Study Drug: Lyrica DPN / Sponsor: Pfizer

Drug Study

Protocol: A0081242 / Diabetic Peripheral Neuropathy

Participation

Study Drug: Vanquix Auto Injector / Sponsor: King Pharmaceuticals

Protocol: K826 05 3001 / Seizure Study

Study Drug: Dimebon / Sponsor: Pfizer

Protocol: B1451027 B1451029 / Alzheimer

Study Drug: DPN / Sponsor: Pfizer

Protocol: A4091031 / Diabetic Peripheral Neuropathy

Study Drug: Vimpat / Sponsor: Schwarz Biosciences, Inc.

Protocol: UCB SP954 / Uncontrollable Seizures

Study Drug: Tanezumab / Sponsor: Pfizer

Protocol: A4091030 / Osteoarthritis

Study Drug: Latrepirdine / Sponsor: Pfizer

Protocol: B1451051 Alzheimer

Study Drug: Carisbamate, Topiramate, Levetiracetam

Sponsor: Ortho McNeil Janssen Scientific Affairs, LLC.

Protocol: Caripsepy 3007 / Partial Onset Seizures

A Randomized, Double and Evaluator Blinded, Ac tive and Placeo

Con trolled, Three Arm, Parallel, 12 Week Study in Adolescent and

Adult Patients with Asthma

Evaluation of Efficacy and Safety of XXX in Children with Asthma

(A Randomized, Double Blind, Placebo Controlled, Two Arm,

Parallel, 4 Week Study in 4 11 Year Old Children with Asthma)

A 3 Month Safety Evaluation Extension to the 12 Week XXX Study in Asthma Patien ts:

A Double Blinded, Placebo Controlled, Parallel, 3 Month Safety in Adolescent and Adult

Patients with Asthma

A 28 Day Study Evaluating the Safety of Ragweed (Ambrosia artemisiifolia) Allergy

Immunotherapy Tablet (SCH 39641/MK 3641) Treatment in Ragweed Allergic Adults

A phase III, multicenter, randomized, double blind, placebo controlled, dose ranging study

to evaluate the efficacy and safety of XXX in patients with chronic idiopathic urticarial

(CIU) who remain symptomatic despite antihistamine treatment (H1)

A randomized, placebo controlled, dose ranging, multi center trial of QAW039 (1 450 mg

p.o.) to investigate the effect on FEV1 and ACQ in patients with moderate to severe,

persistent allergic asthma, inadequately controlled with ICS therapy

A 12 Week Dose ranging Study to Evaluate the Efficacy and Safety of XXX Administered

Twice Daily Compared with Placebo in Adolescent and Adult Subjects with Persistent

Asthma Uncontrolled on Non steroidal Therapy

A Phase 2b, Dose ranging Study to Evaluate the Efficacy and Safety of XXX in Adults with

Uncontrolled Asthma

A 12 Week Randomized, Double Blind, Placebo Controlled, Parallel Group, Safety and

Efficacy Study of XXX Nasal Aerosol in Subjects 6 11 Years with Perennial Allergic Rhinitis

Psychometric Validation of an Asthma Symptom Diary in Adolescent and Adult Patients

with Persistent Asthma

A 12 week, double blind, randomized, multi center, parallel group study evaluating the

efficacy safety, and patient use (User Study) of XXX twice daily compared with XXX AC

(actuation counter) twice daily and XXX twice daily in adult and adolescent asthmatics

A 26 week, randomized, double blind, parallel group, active controlled, multicenter,

multinational safety study evaluating the risk of serious asthma related events during

treatment with XXX, a fixed combination of inhaled corticosteroid XXX and a long acting

B2 agonist (LABA) XXX as compared to treatment with ICS XXX alone in adult and

adolescent (> 12 years of age) patients with asthma

A Phase III, multicenter, randomized, double blind, placebo controlled safety study of XXX

in patients with chronic idiopathic urticarial (CIU) who remain symptomatic despite

treatment with H1 antihistamines, H2 blockers, and/or leukotriene receptor antagonists

A dose ranging study of XXX inhalation powder in children aged 5 11 years with asthma

on a background of inhaled corticosteroid therapy

A dose ranging study of XXX inhalation powder in children age 5 11 years with asthma

A randomized, double and evaluator blinded, active and placebo controlled, three arm,

parallel, 12 week study in adolescent and adult patients with asthma

A 3 month safety evaluation extension to the 12 week study in asthma patients (A double

blinded, placebo controlled, parallel, 3 month safety study in adolescent and adult patients

with asthma)

Evaluation and efficacy and safety of in children with asthma (A randomized, double blind,

placebo controlled, two arm, parallel, 4 week study in 4 11 year old children with asthma)

Contact this candidate